Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002006045-25-000004
Filing Date
2025-11-14
Accepted
2025-11-14 15:19:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4872
  Complete submission text file 0002006045-25-000004.txt   6536
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Subject) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91530 | Film No.: 251485048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 609 SW 8TH ST SUITE 510 BENTONVILLE AR 72712
Business Address 609 SW 8TH ST SUITE 510 BENTONVILLE AR 72712 323-397-1199
SymBiosis Capital Partners, LLC (Filed by) CIK: 0002006045 (see all company filings)

EIN.: 872216774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A